High Pressure Non Invasive Ventilation in Hypercapnic Respiratory Failure

NCT ID: NCT04362787

Last Updated: 2020-07-13

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 52 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2020-08-01
• Study Completion Date: 2023-04-01

Brief Summary

High pressure NIV is a pressure limited ventilation, stating IPAP pressure at 20 cmH2O and gradually increasing pressure up to 30 cmH2O according to patient tolerance.

Detailed Description

Noninvasive ventilation (NIV): refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube). NPPV is well established in the management of acute on chronic hypercapnic respiratory failure secondary to acute exacerbation of COPD (AECOPD), obesity hypoventilation syndrome, and restrictive thoracic disorders.

During the past years NIV was applied by using low pressure inspiratory positive airway pressure (IPAP), which means titrating inspiratory pressure starting at 10 cmH2O and increasing pressure gradually according to patient tolerance maximum up to 20 cm H2O.

There is still about 15% failure rate while using conventional low pressure NIV, this failure rate may be attributed to the following:

1. Still in a number of patients with conventional low pressure NIV, PaCO2, and pH worsen with subsequent deterioration and need for invasive ventilation.

2. Despite lowering PaCO2 value with conventional NIV ventilation but it is not normalized so with minimal derangement in clinical condition of the patient it worsens again.

3. Also abnormally high level PaCO2 may have a negative impact on vital organs.

4. Low pressure may be associated with patient intolerance , and discontinuation of NIV.

Recently high pressure NIV used aiming to improve outcome of NIV. High pressure NIV is a pressure limited ventilation, stating IPAP pressure at 20 cmH2O and gradually increasing pressure up to 30 cmH2O according to patient tolerance. High pressure NIV is expected to improve alveolar ventilation, decreasing dead space ventilation, and work of breathing, so it can improve the outcome result .

Conditions

Acute Hypercapnic Respiratory Failure

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

High pressure _ low pressure non-invasive ventilation

In the high-pressure NIV,52 patients will undergo pressure-limited NPPV at a higher IPAP level. IPAP is initially set at 20 cmH2O and continuously adjusted by increments and decrements of 1-2 cmH2O (up to 30 cmH2O), according to patients' tolerance, to obtain a tidal volume (VT) of 15 mL/kg of IBW.

2- EPAP for patients with COPD will be started at EPAP 5 and will be increased till 7 and for the patients with hypoventilation syndrome will be increased up to EPAP 8.

3-Respiratory rate 10-12 b/min.

High pressure non invasive ventilation in acute hypercapnic respiratory failure

Intervention Type: DEVICE

Usage of High pressure non invasive ventilation in acute hypercapnic respiratory failure

Interventions

High pressure non invasive ventilation in acute hypercapnic respiratory failure

Usage of High pressure non invasive ventilation in acute hypercapnic respiratory failure

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

All patients admitted in Assiut University Hospital and Assiut Police Hospital with acute hypercapnic respiratory failure due to COPD and Obesity hypoventilation syndrome (OHS) indicated for conventional NIV.

Patients who failed on low pressure NIV will be shifted to high pressure NIV with any of these conditions:

1. PH <7.30 or less than admission level.

2. RR > 35b/m or more than admission level.

3. SpO2 < 88%.

Exclusion Criteria

1. Age <18 years.

2. Excessive amount of respiratory secretions or weak cough.

3. Upper airway obstruction.

4. Recent oral, facial or cranial trauma or surgery.

5. Sever abdominal distension.

6. Active upper gastrointestinal bleeding.

7. Cardiac or respiratory arrest.

8. PH<7.25.

9. Arterial oxygen tension /fraction of inspired oxygen (PaO2 / FiO2) <150mmHg.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Assiut University

OTHER

Sponsor Role: lead

Responsible Party

Maha Eissa Helmy Abdelhafeez

Assistant Lecturer

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Khaled Hu Ahmed

Role: STUDY_DIRECTOR

Professor of chest diseases Faculty of medicine Assiut university

Central Contacts

Maha Ei Abdelhafeez, Master

Role: CONTACT

mahaeissa2018@gmail.com

010911477791 ext. 01065854758

Other Identifiers

High pressure

Identifier Type: -

Identifier Source: org_study_id